Heartflow, Inc. Cash Flow Statement
HTFL / Health Care|1 years of annual SEC 10-K data (FY2025-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid. All figures from audited SEC 10-K filings.
Heartflow, Inc. used $54M in operating cash flow and negative free cash flow of $59M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 |
|---|---|
| Net Income | -$116.8M |
| Depreciation & Amortization | $5.4M |
| Operating Cash Flow | -$54.0M |
| Capital Expenditures | $5.0M |
| Free Cash Flow | -$59.0M |
| FCF Margin | -33.5% |